Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.
Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO. · Investor's Business Daily

In This Article:

Teva stock retreated Wednesday after the pharmaceutical company reported a drop in fourth-quarter revenue.